Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Type 1 Diabetes Mellitus
Condition: Initial
Dose: Subcutaneous Injection – 0.2-0.4 units/kg/day
Frequency: divided every 8 hours or more frequently
Note: Dosage must be based on the results of blood and urine glucose tests and carefully individualized.
Indication: Type 1 Diabetes Mellitus
Condition: Maintenance
Dose: Subcutaneous Injection – 0.5-1 unit/kg/day
Frequency: divided every 8 hours or more frequently
Note: In insulin-resistant patients (e.g., due to obesity), substantially higher daily insulin may be required.

Child Dose

Clinical InformationAdministration Information
Indication: Type 1 Diabetes Mellitus
Condition: Initial
Dose: Subcutaneous – 0.2-0.4 unit/kg/day
Frequency: divided every 8 hours or more frequently
Indication: Type 1 Diabetes Mellitus
Condition: Maintenance
Dose: Subcutaneous – 0.5-1 unit/kg/day
Frequency: divided every 8 hours or more frequently
Note: in insulin-resistant patients (for example, due to obesity), substantially higher daily insulin may be required

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Not specified – Dose adjustments may be needed
Note: Renal impairment: Dose adjustments may be needed.
Administration
  • Take as directed
  • Inject before meals
Side Effect

Drug Interaction

Drug NameRisk Factors
Beta-blockers (Propranolol, Metoprolol, Atenolol, Bisoprolol, Carvedilol, Nadolol, Timolol, Sotalol)
Possible absence of hypoglycaemic warning symptoms
Corticosteroids (Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Hydrocortisone), Danazol, Diazoxide, Diuretics, Glucagon, Isoniazid, Phenothiazine derivatives, Somatropin, Sympathomimetic agents, Thyroid hormones, Oestrogens, Progestins, Protease inhibitors, Atypical Antipsychotics (Haloperidol, Risperidone, Quetiapine, Olanzapine, Clozapine, Aripiprazole)
Decreased hypoglycaemic effect

Disease Interaction

Disease NameRisk Factors
Hypoglycaemia
Can dangerously lower blood sugar

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.